Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation

Bone Marrow Transplantation
C AlmiciV Rizzoli

Abstract

Umbilical cord blood (UCB) progenitor cells have been demonstrated to possess significant advantages over bone marrow (BM), in terms of proliferative capacity and immunologic reactivity. Therefore, UCB has been recently considered an attractive potential alternative to BM as a source of hematopoietic progenitor cells for clinical applications. Since several programs throughout the world are currently evaluating the feasibility of large-scale UCB banking for unrelated transplants, it was the aim of this study to evaluate whether cryopreservation procedures might heavily impair the clonogenic capacity, the feasibility of CD34+ selection and the ex vivo expansion potential of UCB progenitor cells. UCB samples were collected and cryopreserved as unseparated (n = 21) or mononuclear (MNC) cells (n = 15) within 12 h from delivery, and evaluated for viability, immunophenotype, cell and progenitor numbers after a minimum stay in liquid nitrogen of 6 months (range 6-14 months). Viability was always > 97% and no statistically significant difference was detected by flow cytometric analysis. Clonogenic recovery from unseparated cells was 80-87% for HPP-CFC, CFU-GEMM, BFU-E and CFU-GM, and from MNC cells ranged from 82 to 91% for LTC-IC, CFU...Continue Reading

Citations

Sep 6, 2003·Journal of Immunological Methods·A CostantiniM Montroni
Apr 18, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S J Fasouliotis, J G Schenker
Oct 29, 2010·Human Gene Therapy·Marta Claudia FrittoliSarah Marktel
Aug 3, 2006·BMC Cell Biology·Tuija KekarainenTaina Jaatinen
Jan 21, 2010·Microvascular Research·Toyoaki Murohara
Jul 17, 2004·Journal of Cellular and Molecular Medicine·Mihaela ChivuC Cernescu
Apr 30, 2013·Transfusion·Jolanta Antoniewicz-PapisMagdalena Łętowska
Jun 2, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Janet AyelloMitchell S Cairo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.